1. Home
  2. Medical Devices & Consumables
  3. Global Market Analysis Of Cervical Cancer Diagnostics Market By Test Type, By End User, And By Region (Global Market Forecast To 2027)

Global Market Analysis Of Cervical Cancer Diagnostics Market By Test Type, By End User, And By Region (Global Market Forecast To 2027)

Publication Month: Jun 2020 | No. of Pages: 120 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Definition

The Global Cervical Cancer Diagnostics market is estimated at $ 8.75 billion in 2019, and expected to reach $ 13.74 billion by 2027, with a CAGR of 5.8% from 2020 to 2027.

Cervix is the lower part of the uterus that is connected to the vagina, and the cancer that occurs in the cells of the cervix is called as cervical cancer. With the help of certain vaccines most of the cases of cervical cancer that are caused by HPV infections can be prevented.

Market Dynamics

The Global Cervical Cancer Diagnostics market is primarily driven by factors such as the growing occurrences of obesity, HPV infection, and cervical cancer in the women at the age of 20-60 years; growing demand for advanced diagnostics procedures; technological innovations in the field of cancer diagnostics; growing favorable reimbursement policies; growing awareness among population regarding preventive care and treatment; growing numbers of female smokers populations; growing incidences of unsafe sex amongst teenagers; government initiatives towards prevention of cervical cancer; growing focus on research and development; are some of the market dynamics.

Market Segmentation

The Global Cervical Cancer Diagnostics Market is mainly classified based on Test Type, End User, and Region.

  • Based on Test Type, the market is further segmented into Papanicolaou (PAP) Testing, Human Papilloma Virus (HPV) Testing, Cystoscopy, Cervical Biopsies, Colposcopy, and Other Diagnostics Test
  • Based on End User, the market is further segmented into Hospitals, Specialty Clinics, Diagnostics Centers, Cancer Care Centers, and Other Users

Regional Analysis

Based on geography, the Global Cervical Cancer Diagnostics market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape

Global Cervical Cancer Diagnostics Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global Cervical Cancer Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2019-2027, this study provides the Global Cervical Cancer Diagnostics sales, revenue and market share for each player covered in this report.

The major players covered in Global Cervical Cancer Diagnostics are Hologic Inc., Abbott Molecular, Qiagen, F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc., Becton (Dickinson and Company), Arbor Vita Corporation, Guided Therapeutics Inc., Cooper Surgical Inc., OncoHealth Corporation, Olympus, Ascon Medical Instruments, Cardinal Health, and other prominent players.

Cervical Cancer Diagnostics Market Key Segments:

By Test Type

  • Papanicolaou (PAP) Testing
  • Human Papilloma Virus (HPV) Testing
  • Cystoscopy
  • Cervical Biopsies
  • Colposcopy
  • Other Diagnostics Test

By End User

  • Hospitals
  • Specialty Clinics
  • Diagnostics Centers
  • Cancer Care Centers
  • Other Users

By Region

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1 Market Overview
1.1 Cervical Cancer Diagnostics Introduction
1.2 Market Analysis by Test Type

1.2.1 Overview: Global Cervical Cancer Diagnostics Revenue by Test Type: 2019 VS 2021 VS 2027
1.2.2 Papanicolaou (PAP) Testing

1.2.3 Human Papilloma Virus (HPV) Testing

1.2.4 Cystoscopy

1.2.5 Cervical Biopsies

1.2.6 Colposcopy

1.2.7 Other Diagnostics Test

1.3 Market Analysis by End User

1.3.1 Overview: Global Cervical Cancer Diagnostics Revenue by End User: 2019 VS 2021 VS 2027
1.3.2 Hospitals

1.3.3 Diagnostics Centers

1.3.4 Specialty Clinics

1.3.5 Cancer Care Centers

1.3.6 Other Users

1.4 Overview of Global Cervical Cancer Diagnostics Market
1.4.1 Global Cervical Cancer Diagnostics Market Status and Outlook (2019-2027)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk

1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hologic Inc.
2.1.1 Hologic Inc. Details
2.1.2 Hologic Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Hologic Inc. SWOT Analysis
2.1.4 Hologic Inc. Product and Services
2.1.5 Hologic Inc. Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.2 Abbott Molecular 
2.2.1 Abbott Molecular Details
2.2.2 Abbott Molecular Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Abbott Molecular SWOT Analysis
2.2.4 Abbott Molecular Product and Services
2.2.5 Abbott Molecular Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Qiagen SWOT Analysis
2.3.4 Qiagen Product and Services
2.3.5 Qiagen Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.4 F. Hoffmann-La Roche Ltd. 
2.4.1 F. Hoffmann-La Roche Ltd. Details
2.4.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.4.4 F. Hoffmann-La Roche Ltd. Product and Services
2.4.5 F. Hoffmann-La Roche Ltd. Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.5 Quest Diagnostics Inc.
2.5.1 Quest Diagnostics Inc. Details
2.5.2 Quest Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Quest Diagnostics Inc. SWOT Analysis
2.5.4 Quest Diagnostics Inc. on Product and Services
2.5.5 Quest Diagnostics Inc. Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.6 Becton (Dickinson and Company)
2.6.1 Becton (Dickinson and Company) Details
2.6.2 Becton (Dickinson and Company) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Becton (Dickinson and Company) SWOT Analysis
2.6.4 Becton (Dickinson and Company) Product and Services
2.6.5 Becton (Dickinson and Company) Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.7 Arbor Vita Corporation 
2.7.1 Arbor Vita Corporation Details
2.7.2 Arbor Vita Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Arbor Vita Corporation SWOT Analysis
2.7.4 Arbor Vita Corporation Product and Services
2.7.5 Arbor Vita Corporation Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.8 Guided Therapeutics Inc. 
2.8.1 Guided Therapeutics Inc. Details
2.8.2 Guided Therapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Guided Therapeutics Inc. SWOT Analysis
2.8.4 Guided Therapeutics Inc. Product and Services
2.8.5 Guided Therapeutics Inc. Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.9 Cooper Surgical Inc. 
2.9.1 Cooper Surgical Inc. Details
2.9.2 Cooper Surgical Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cooper Surgical Inc. SWOT Analysis
2.9.4 Cooper Surgical Inc. Product & Services
2.9.5 Cooper Surgical Inc. Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.10 OncoHealth Corporation 
2.10.1 OncoHealth Corporation Details
2.10.2 OncoHealth Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 OncoHealth Corporation SWOT Analysis
2.10.4 OncoHealth Corporation Product & Services
2.10.5 OncoHealth Corporation Cervical Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.11 Other Players

3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cervical Cancer Diagnostics Sales and Market Share by Manufacturer (2019-2020)
3.2 Global Cervical Cancer Diagnostics Revenue and Market Share by Manufacturer (2019-2020)
3.3 Market Concentration Rate
3.3.1 Top 3 Cervical Cancer Diagnostics Manufacturer Market Share in 2019 & 2020
3.3.2 Top 6 Cervical Cancer Diagnostics Manufacturer Market Share in 2019 & 2020
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cervical Cancer Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Cervical Cancer Diagnostics Sales and Market Share by Regions (2019-2020)
4.1.2 Global Cervical Cancer Diagnostics Revenue and Market Share by Regions (2019-2020)
4.2 North America Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
4.3 Europe Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
4.4 Asia-Pacific Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
4.5 South America Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
4.6 Middle East and Africa Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
5 North America by Country
5.1 North America Cervical Cancer Diagnostics Sales, Revenue and Market Share by Country
5.1.1 North America Cervical Cancer Diagnostics Sales and Market Share by Country (2019-2020)
5.1.2 North America Cervical Cancer Diagnostics Revenue and Market Share by Country (2019-2020)
5.2 United States Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
5.3 Canada Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
5.4 Mexico Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
6 Europe by Country
6.1 Europe Cervical Cancer Diagnostics Sales, Revenue and Market Share by Country
6.1.1 Europe Cervical Cancer Diagnostics Sales and Market Share by Country (2019-2020)
6.1.2 Europe Cervical Cancer Diagnostics Revenue and Market Share by Country (2019-2020)
6.2 Germany Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
6.3 UK Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
6.4 France Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
6.5 Russia Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
6.6 Italy Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cervical Cancer Diagnostics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cervical Cancer Diagnostics Sales and Market Share by Regions (2019-2020)
7.1.2 Asia-Pacific Cervical Cancer Diagnostics Revenue and Market Share by Regions (2019-2020)
7.2 China Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
7.3 Japan Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
7.4 Korea Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
7.5 India Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
7.6 Southeast Asia Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
7.7 Australia Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
8 South America by Country
8.1 South America Cervical Cancer Diagnostics Sales, Revenue and Market Share by Country
8.1.1 South America Cervical Cancer Diagnostics Sales and Market Share by Country (2019-2020)
8.1.2 South America Cervical Cancer Diagnostics Revenue and Market Share by Country (2019-2020)
8.2 Brazil Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
8.3 Argentina Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cervical Cancer Diagnostics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cervical Cancer Diagnostics Sales and Market Share by Country (2019-2020)
9.1.2 Middle East & Africa Cervical Cancer Diagnostics Revenue and Market Share by Country (2019-2020)
9.2 Saudi Arabia Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
9.3 Turkey Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
9.4 Egypt Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
9.5 South Africa Cervical Cancer Diagnostics Sales and Growth Rate (2019-2020)
10 Global Cervical Cancer Diagnostics Market Segment by Test Type
10.1 Global Cervical Cancer Diagnostics Sales Market Share by Test Type (2019-2020)
10.2 Global Cervical Cancer Diagnostics Revenue Market Share by Test Type (2019-2020)
10.3 Global Cervical Cancer Diagnostics Price by Test Type (2019-2020)

11 Global Cervical Cancer Diagnostics Market Segment by End User 
11.1 Global Cervical Cancer Diagnostics Sales Market Share by End User (2019-2020)
11.2 Global Cervical Cancer Diagnostics Revenue Market Share by End User (2019-2020)
11.3 Global Cervical Cancer Diagnostics Price by End User (2019-2020)

12 Market Forecast
12.1 Global Cervical Cancer Diagnostics Sales, Revenue and Growth Rate (2021-2027)
12.2 Cervical Cancer Diagnostics Market Forecast by Regions (2021-2027)
12.2.1 North America Cervical Cancer Diagnostics Market Forecast (2021-2027)
12.2.2 Europe Cervical Cancer Diagnostics Market Forecast (2021-2027)
12.2.3 Asia-Pacific Cervical Cancer Diagnostics Market Forecast (2021-2027)
12.2.4 South America Cervical Cancer Diagnostics Market Forecast (2021-2027)
12.2.5 Middle East & Africa Cervical Cancer Diagnostics Market Forecast (2021-2027)
12.3 Cervical Cancer Diagnostics Market Forecast by Test Type (2021-2027)
12.3.1 Global Cervical Cancer Diagnostics Sales Forecast by Test Type (2021-2027)
12.3.2 Global Cervical Cancer Diagnostics Market Share Forecast by Test Type (2021-2027) 
12.4 Cervical Cancer Diagnostics Market Forecast by End User (2021-2027)
12.4.1 Global Cervical Cancer Diagnostics Sales Forecast by End User (2021-2027)
12.4.2 Global Cervical Cancer Diagnostics Market Share Forecast by End User (2021-2027)

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About Us 

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets